AbbVie’s stock pops 4% after earnings beat estimates and company offers upbeat view of 2025
AbbVie Inc.’s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025. North Chicago, Ill.-based AbbVie had a loss per share of 2 ...